Details of the Drug Formulaction

General Information of Drug Formulation (ID: F12075)

• Formulation Name: Lisdexamfetamine 30 mg tablet
• Company: Shire

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Lisdexamfetamine	(DM6W8V5)	Attention deficit hyperactivity disorder	6A05.Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	(E00625)	Not Available	Disintegrant
Magnesium stearate	(E00208)	11177	lubricant
Mannitol	(E00103)	6251	Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sucralose	(E00370)	71485	Flavoring agent